345 related articles for article (PubMed ID: 32016973)
21. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
Wei S; Wang K; Huang X; Zhao Z; Zhao Z
Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
[TBL] [Abstract][Full Text] [Related]
24. Circ0021205 aggravates the progression of non-small cell lung cancer by targeting miRNA-16-5p/VEGFA.
Yang Y; Huang XJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):213-221. PubMed ID: 31957834
[TBL] [Abstract][Full Text] [Related]
25. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
26. MicroRNA-507 represses the malignant behaviors of non-small cell lung cancer via targeting zinc finger E-box binding homeobox 2.
Lv HL; Li ZL; Song YB
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9955-9964. PubMed ID: 31799665
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in non-small-cell lung cancer.
Li X; Zhu J; Liu Y; Duan C; Chang R; Zhang C
Cancer Sci; 2019 Jun; 110(6):1883-1896. PubMed ID: 30955235
[TBL] [Abstract][Full Text] [Related]
28. MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.
Fang QY; Deng QF; Luo J; Zhou CC
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2548-2556. PubMed ID: 32196605
[TBL] [Abstract][Full Text] [Related]
29. MiR-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2.
Shen YY; Cui JY; Yuan J; Wang X
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5554-5561. PubMed ID: 30229828
[TBL] [Abstract][Full Text] [Related]
30. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
[TBL] [Abstract][Full Text] [Related]
31. microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
Chen GM; Zheng AJ; Cai J; Han P; Ji HB; Wang LL
J Cell Biochem; 2018 Jan; 119(1):885-895. PubMed ID: 28661070
[TBL] [Abstract][Full Text] [Related]
32. miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer.
Hong-Yuan W; Xiao-Ping C
Indian J Cancer; 2015 Dec; 52 Suppl 3():E168-71. PubMed ID: 27453416
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
Ma XR; Xu YL; Qian J; Wang Y
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA hsa_circ_0072309 inhibits non-small cell lung cancer progression by sponging miR-580-3p.
Pang W; Huang F; Zhang X; Ye M; Huang Y; Huang X; Pang J; Cai C; Wang Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32293004
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
36. MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer.
Liao XH; Xie Z; Guan CN
Neoplasma; 2018 Sep; 65(5):673-682. PubMed ID: 30249107
[TBL] [Abstract][Full Text] [Related]
37. MiR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells.
Cao M; Li Y; Lu H; Meng Q; Wang L; Cai L; Dong X
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1661-70. PubMed ID: 24898878
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
39. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells.
Geng Q; Li Z; Li X; Wu Y; Chen N
J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335
[TBL] [Abstract][Full Text] [Related]
40. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
Lu YJ; Liu RY; Hu K; Wang Y
Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]